Allergen Extract Clinical Prior Authorization Revision Coming February 24
FirstCare will revise the Allergen Extracts clinical prior authorization criteria on February 24, 2020. This change reflects the Food and Drug Administration guidance expanding the indication for Oralair for people 5 years of age and older. The previous indication was for 10 years of age and older. Additionally, FirstCare will change the contraindication diagnosis to include only severe, uncontrolled asthma diagnoses. Oralair is part of the Allergen Extract clinical prior authorization criteria. All clinical edit criteria can be found here.
* Required field
ATTENTION: By clicking “Continue”, you will be leaving the FirstCare Medicare Dual SNP (HMO SNP) site pages. If you wish to remain on these pages, simply click “Cancel” or close this box.